Skip to main content

Table 1 Clinical manifestations and laboratory features

From: Elevated serum B-cell activator factor levels predict rapid progressive interstitial lung disease in anti-melanoma differentiation associated protein 5 antibody positive dermatomyositis

Parameters

NC

ASS

MDA5+

p-value

Case number

20

20

39

 

Gender, female, no. (%)

11(55%)

14(70%)

27(69.23%)

0.704

Age, mean ± SD, years

48.95 ± 11.71

54.70 ± 11.87

53.94 ± 13.46

0.834

Medical history, months

 

10.90 ± 16.35

3.00 ± 2.75

0.051

Medication

 - glucocorticoids, no. (%)

 

8 (40%)

18 (46.15%)

0.652

 - immunosuppressants, no. (%)

 

7(35%)

13 (33.33%)

0.898

Interstitial lung disease, no. (%)

   

0.120

 non-ILD

 

2 (10%)

7 (17.95%)

 

 ILD

 

12 (60%)

12 (30.77%)

 

 RP-ILD

 

6 (30%)

20 (51.28%)

 

Myasthenia, no. (%)

 

1 (5%)

14 (35.89%)

0.010

Gottron’s sign, no. (%)

 

4 (20%)

23 (58.90%)

0.004

Heliotrope rash, no. (%)

 

1 (5%)

11 (28.20%)

0.044

V sign, no. (%)

 

1 (5%)

15 (38.46%)

0.006

Shawl sign, no. (%)

 

1 (5%)

10 (25.64%)

0.079

Periungual erythema, no. (%)

 

0 (0%)

10 (25.64%)

0.012

Skin ulcers, no. (%)

 

0 (0%)

7 (17.95%)

0.083

Mechanic’s hands, no. (%)

 

4 (20%)

13 (33.33%)

0.284

Arthritis, no. (%)

 

1 (5%)

10 (25.64%)

0.079

CK, median (range), IU/L

 

64.00 (39.75–92.50)

47.00 (29.00–105.00)

0.659

LDH, median (range), U/L

 

268.50 (210.25–367.00)

319.00 (276.00–418.00)

0.070

ESR, median (range), mm/H

 

36.00 (7.00–45.00)

36.00 (25.00–48.75)

0.761

SF, mean ± SD, ng/mL

 

258.20 ± 156.77

916.94 ± 771.48

0.001

CRP, median (range), mg/L

 

6.30 (1.62–27.82)

4.94 (2.30–11.40)

0.692

BAFF, mean ± SD, pg/mL

2486.28 ± 767.97

2540.89 ± 1403.04

3882.32 ± 1880.09

0.001

  1. Data are presented as mean ± SD or median (range) or case number (percentage); Student’s t-test, Pearson’s Chi square test and analysis of variance (ANOVA) were used to analysis. All of the clinical and laboratory parameters were obtained at the first evaluation
  2. Anti-MDA5+DM anti-melanoma differentiation-associated protein 5 antibody positive dermatomyositis, RP-ILD rapidly progressive interstitial lung disease, CK cytokeratin, CRP C-reactive protein, LDH dehydrogenase, ESR erythrocyte sedimentation rate, SF serum ferritin, BAFF B-cell activating factor